| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| GLPG 0974 |
MPMKMQHJHDHPBE-RUZDIDTESA-N |
1391076-61-1 |
詳細(xì)
|
| Gefitinib-based PROTAC 3 |
Gefitinib-based PROTAC 3 |
2230821-27-7 |
詳細(xì)
|
| GSHtracer |
2-氰基-N,N-二甲基-3-(2,3,6,7-四氫-11-氧代-1H,5H,11H-[1]苯并吡喃并[6,7,8-IJ]喹啉-10-基)-2-丙烯酰胺 |
1479071-34-5 |
詳細(xì)
|
| GSK 2837808A |
1445879-21-9 |
1445879-21-9 |
詳細(xì)
|
| G 28UCM |
UCM05 |
1094451-90-7 |
詳細(xì)
|
| GN 44028 |
GN44028 |
1421448-26-1 |
詳細(xì)
|
| Gap19 |
Gap19 |
1507930-57-5 |
詳細(xì)
|
| Goserelin acetate |
醋酸戈舍瑞林 |
145781-92-6 |
詳細(xì)
|
| GTP 14564 |
1-PHENYL-3-H-8-OXA-2,3-DIAZA-CYCLOPENTA[A]INDEN |
34823-86-4 |
詳細(xì)
|
| GA3-AM |
GA3-AM |
1373154-68-7 |
詳細(xì)
|
| Gavestinel |
GAVESTINEL |
153436-38-5 |
詳細(xì)
|
| GSK 269962 |
N-[3-[[2-(4-氨基呋咱-3-基)-1-乙基-1H-咪唑并[4,5-C]吡啶-6-基]氧]苯基]-4-[[2-(4-嗎啉基)乙基]氧]苯甲酰胺 |
850664-21-0 |
詳細(xì)
|
| GSK 5959 |
化合物GSK 5959 |
901245-65-6 |
詳細(xì)
|
| GRI 977143 |
GRI977143; GRI-977143 |
325850-81-5 |
詳細(xì)
|
| GSK 4112 |
1216744-19-2 |
1216744-19-2 |
詳細(xì)
|
| Ginsenoside F1 |
人參皂苷 F1 |
53963-43-2 |
詳細(xì)
|
| gamma-Mangostin |
γ-倒捻子素 |
31271-07-5 |
詳細(xì)
|
| Glycocholic acid hydrate |
甘氨膽酸 |
1192657-83-2 |
詳細(xì)
|
| Glutaconic acid |
戊烯二酸 |
1724-02-3 |
詳細(xì)
|
| Gly-gly-leu |
甘氨酰-甘氨酰-L-亮氨酸 |
14857-82-0 |
詳細(xì)
|
| GMX1778 |
N-[6-(4-氯苯氧基)己基]-N'-氰基-N''-4-吡啶基胍 |
200484-11-3 |
詳細(xì)
|
| Gly-Gln monohydrate |
甘氨酰-L-谷氨酰胺 |
172669-64-6 |
詳細(xì)
|
| Glycidyl 4-methoxyphenyl ether |
2,3-環(huán)氧丙基-4-甲氧基苯基醚 |
2211-94-1 |
詳細(xì)
|
| 4-(2-Naphthyl)-4-oxobutanoic acid |
4-(2-萘基)-4-氧代丁酸 |
1590-22-3 |
詳細(xì)
|
| GR127935 hydrochloride |
GR 127935 HYDROCHLORIDE HYDRATE |
148642-42-6 |
詳細(xì)
|
| Glycolaldehyde dimer |
乙醇醛二聚體(羥基乙醛二聚體) |
23147-58-2 |
詳細(xì)
|
| Gilteritinib |
吉列替尼 |
1254053-43-4 |
詳細(xì)
|
| Ginsenoside Compound K |
20(S)-人參皂苷 C-K |
39262-14-1 |
詳細(xì)
|
| Geranic acid |
垅牛兒酸 |
459-80-3 |
詳細(xì)
|
| Gemifloxacin mesylate |
甲磺酸吉米沙星 |
210353-53-0 |
詳細(xì)
|
| GI254023X |
(ALPHAR)-N-[(1S)-2,2-二甲基-1-[(甲基氨基)羰基]丙基]-ALPHA-[(1S)-1-(甲酰基羥基氨基)乙基]苯戊酰胺 |
260264-93-5 |
詳細(xì)
|
| GSK2578215A |
5-(2-氟-4-吡啶基)-2-(苯基甲氧基)-N-3-吡啶基苯甲酰胺 |
1285515-21-0 |
詳細(xì)
|
| GNF-7 |
GNF-7 |
839706-07-9 |
詳細(xì)
|
| Graphite, fluorinated, polymer |
氟化石墨烯 |
51311-17-2 |
詳細(xì)
|
| Gatifloxacin Hydrate |
加替沙星 水合物 |
614751-80-3 |
詳細(xì)
|
| N-Glycylglycine ethyl ester hydrochloride |
H-GLY-GLY-OET旽CL |
2087-41-4 |
詳細(xì)
|
| 20(R)-Ginsenoside Rh2 |
20(R)-人參皂苷 RH2 |
112246-15-8 |
詳細(xì)
|
| GANT58 |
4,44喬,4喬(2,3,4,5-Thiophentetrayl)tetrakis-pyridine |
64048-12-0 |
詳細(xì)
|
| Tenofovir alafenamide |
泰諾福韋艾拉酚胺 |
379270-37-8 |
詳細(xì)
|
| GW7647 |
2-[[4-[2-[[環(huán)己基氨基)羰基](4-環(huán)己基丁基)氨基]乙基]苯基]硫基]-2-甲基丙酸 |
265129-71-3 |
詳細(xì)
|
| GSK6853 |
GSK6853 |
1910124-24-1 |
詳細(xì)
|
| GSK 4716 |
GSK 4716 |
101574-65-6 |
詳細(xì)
|
| D-Glucopyranose, oligomeric, C9-11-alkyl glycoside |
ELUGENT(TM) DETERGENT |
132778-08-6 |
詳細(xì)
|
| GANT 61 |
2,2'-[[二氫-2-(4-吡啶基)-1,3(2H,4H)-嘧啶二基]二(亞甲基)]二[N,N-二甲基苯胺] |
500579-04-4 |
詳細(xì)
|
| GR 46611 |
3-[3-(2-DIMETHYLAMINOETHYL)-1H-INDOL-5-YL]-N-(4-METHOXYBENZYL)ACRYLAMIDE |
185259-85-2 |
詳細(xì)
|
| GBR 12909 dihydrochloride |
伐諾司林二鹽酸鹽 |
67469-78-7 |
詳細(xì)
|
| GDC-0941 dimesylate |
GDC0941 |
957054-33-0 |
詳細(xì)
|
| Glycohyodeoxycholic acid |
甘氨豬去氧膽酸 |
13042-33-6 |
詳細(xì)
|
| GYY 4137 |
(4-甲氧基苯基)嗎啉基-二硫代膦酸與嗎啉的化合物 |
106740-09-4 |
詳細(xì)
|
| Ginsenoside Rg3 |
20（R）-人參皂苷Rg3 |
38243-03-7 |
詳細(xì)
|
| GM 6001 |
伊洛馬司他 |
142880-36-2 |
詳細(xì)
|
| Glycyl-L-Histidyl-L-Lysine |
藍(lán)銅勝肽 |
49557-75-7 |
詳細(xì)
|
| Ghrelin (human) (acetate) |
來(lái)諾瑞林 |
258279-04-8 |
詳細(xì)
|
| GBR 13069 dihydrochloride |
GBR-13069 DIHYDROCHLORIDE |
67469-45-8 |
詳細(xì)
|
| GF 109203X hydrochloride |
3-[1-[3-(二甲基氨基)丙基]-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮單鹽酸鹽 |
176504-36-2 |
詳細(xì)
|
| GMQ hydrochloride |
GMQ hydrochloride |
5361-15-9 |
詳細(xì)
|
| Glycinamide |
甘氨酰胺 |
598-41-4 |
詳細(xì)
|
| GSK-J2 |
N-[2-(3-吡啶基)-6-(1,2,4,5-四氫-3H-3-苯并氮雜卓-3-基)-4-嘧啶基]-BETA-丙氨酸 |
1394854-52-4 |
詳細(xì)
|
| Ginsenoside F2 |
人參皂苷 F2 |
62025-49-4 |
詳細(xì)
|
| GSK-1016790A |
CS-2774 |
942206-85-1 |
詳細(xì)
|
| GS 39783 |
化合物 T22813 |
39069-52-8 |
詳細(xì)
|
| Gp 1a |
N-(Piperidin-1-yl)-1-(2,4-dichlorophenyl)-1,4-dihydro-6-methylindeno[1,2-c]pyrazole-3-carboxamide |
511532-96-0 |
詳細(xì)
|
| Glyceryl monostearate |
單硬脂酸甘油酯 |
31566-31-1 |
詳細(xì)
|
| GTS-21 dihydrochloride (DMBX-A) |
GTS-21鹽酸鹽 |
156223-05-1 |
詳細(xì)
|
| Glucaric acid calcium salt (Calcium saccharate) |
葡萄糖二酸鈣 |
5793-89-5 |
詳細(xì)
|
| Gap26 trifluoroacetate |
GAP26 |
197250-15-0 |
詳細(xì)
|
| Go 6976 |
5,6,7,13-四氫-13-甲基-5-氧代-12H-吲哚并[2,3-A]吡咯并[3,4-C]咔唑-12-丙腈 |
136194-77-9 |
詳細(xì)
|
| Guggulsterone（pregna-4,17-diene-3,16-dione） |
香膠甾酮 |
95975-55-6 |
詳細(xì)
|
| GSK484 hydrochloride |
CS-2265 |
1652591-81-5 |
詳細(xì)
|
| GSK503 |
化合物GSK503 |
1346572-63-1 |
詳細(xì)
|
| STING agonist-1 |
702662-50-8 |
702662-50-8 |
詳細(xì)
|
| GSK872 |
GSK872 |
1346546-69-7 |
詳細(xì)
|
| GSK-J4 |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氫-3H-3-苯并氮雜卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯 |
1373423-53-0 |
詳細(xì)
|
| Gap 27（TFA) |
Gap 27 |
198284-64-9 |
詳細(xì)
|
| GTP-γ-S-Li4 |
鳥苷-5ˊ-O-(3-硫代三磷酸)四鋰鹽 |
94825-44-2 |
詳細(xì)
|
| GNE7915 |
GNE7915 |
1351761-44-8 |
詳細(xì)
|
| GSK2656157 |
GSK2656157 |
1337532-29-2 |
詳細(xì)
|
| Gadolinium(III) chloride hydrate |
三氯化釓六水合物 |
19423-81-5 |
詳細(xì)
|
| GppNHp |
GPPNHP,不可水解的GTP類似物 |
64564-03-0 |
詳細(xì)
|
| Gold(I) iodide |
碘化金 |
10294-31-2 |
詳細(xì)
|
| GNE 2861 |
GNE-2861 |
1394121-05-1 |
詳細(xì)
|
| G-1 |
881639-98-1 |
881639-98-1 |
詳細(xì)
|
| GGsTop |
GGSTOPTM |
926281-37-0 |
詳細(xì)
|
| GSK 2239633A |
1240516-71-5 |
1240516-71-5 |
詳細(xì)
|
| GSK 650394 |
2-環(huán)戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 |
890842-28-1 |
詳細(xì)
|
| GSK 137647 |
4-甲氧基-N-(2,4,6-三甲基苯)苯磺酰胺 |
349085-82-1 |
詳細(xì)
|
| GS 6201 |
3-乙基-1-丙基-8-(1-(3-(三氟甲基)芐基)-1H-吡唑-4-基)-1H-嘌呤-2,6(3H,8H)-二酮 |
752222-83-6 |
詳細(xì)
|
| GRL 0617 |
5-Amino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide |
1093070-16-6 |
詳細(xì)
|
| GSK 2193874 |
GSK2193874游離態(tài) |
1336960-13-4 |
詳細(xì)
|
| GT 949 |
GT 949 |
460330-27-2 |
詳細(xì)
|
| GSK 583 |
6-(叔丁基磺?；?-N-(5-氟-1H-吲唑-3-基)喹啉-4-胺 |
1346547-00-9 |
詳細(xì)
|
| Tricyclohexylphosphine[3-phenyl-1H-inden-1-ylidene][1,3-bis(2,4,6-triMethylphenyl)-4,5-dihydroiMidazol-2-ylidene]rutheniuM(II) |
Grubbs Catalyst? M202為 Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene](3-phenyl-1H-inden-1-ylidene)(tricyclohexylphosphine)ruthenium(II) |
536724-67-1 |
詳細(xì)
|
| GSK 591 dihydrochloride |
GSK 591 二鹽酸鹽 |
2320953-89-5 |
詳細(xì)
|
| GS 441524 |
GS-441524 |
1191237-69-0 |
詳細(xì)
|
| GBR 12935 dihydrochloride |
GBR-12935 dihydrochloride |
67469-81-2 |
詳細(xì)
|
| G-15 |
G-15,GPER拮抗劑 |
1161002-05-6 |
詳細(xì)
|
| GSK 2830371 |
GSK 2830371 |
1404456-53-6 |
詳細(xì)
|
| GNF 5837 |
GNF 5837 |
1033769-28-6 |
詳細(xì)
|
| GR 89696 fumarate |
GR 89696 FUMARATE |
126766-32-3 |
詳細(xì)
|
| Grubbs Catalyst M800 |
(SP-5-31)-雙[1,3-雙(2,4,6-三甲基苯基)-2-咪唑啉亞基]二氯(3-苯基-1H-茚-1-亞基)釕 |
1383684-54-5 |
詳細(xì)
|